Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Bo'ao Winhealth Rare Disease Medical Center and Ali Health Jointly Launched the "Global Drug Information Platform for Rare Diseases" 2021-09-27 21:00
Immunoforge Inc. receives U.S. FDA ODD for Treatment of Polymyositis 2021-09-27 21:00
JW Therapeutics Announces IND Approval for the Clinical Trial of JWCAR129 2021-09-27 20:00
Senhwa Announces Acceptance of Early Positive COVID-19 Phase II Study Abstract for Presentation at the ISIRV-WHO Conference 2021-09-27 19:20
Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC 2021-09-27 19:02
GenScript ProBio Congratulates EyeGene for Clinical Trial Approval for mRNA COVID-19 Vaccine in South Korea 2021-09-27 18:35
Lipidor announces approval to start Phase III clinical study of drug candidate AKP02 for treatment of psoriasis 2021-09-27 17:37
Mindray Launches New MC-80 Automated Digital Cell Morphology Analyzer, Taking Morphology Analysis to the Next Level 2021-09-27 16:20
Clever Culture Systems Appoints Thermo Fisher Scientific as Exclusive US APAS® Distributor 2021-09-27 16:00
Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002 2021-09-27 08:30
Innovent and AnHeart Announce Interim Data from Phase 2 Trial of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting 2021-09-27 08:00
Kintor Pharma Announces Brazil's ANVISA Approves Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients 2021-09-26 23:09
GenScript ProBio and AskGene Enter into a Non-exclusive License of A sdAb Targeting Immune Checkpoint Target 2021-09-26 22:28
JW Therapeutics Announces Updated 1-year Follow-up Result of Relmacabtagene Autoleucel Injection At the 24th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) 2021-09-26 20:00
Boan Biotech to Present the Pre-clinical Data of Its Proprietary CD3+ T-cell Engager Platform and CEA/CD3 Bispecific Antibody at World Bispecific Summit 2021-09-26 10:12
Qiming's Portfolio Company Broncus Lists on Main Board of HKEx 2021-09-24 14:10
New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA 2021-09-24 14:09
Everest Medicines Announces Approval of Investigational New Drug Application by China NMPA for SPR206 2021-09-24 13:56
Broncus Lists on Main Board of HKEx 2021-09-24 11:52
New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA 2021-09-24 09:18
1 338 339 340 341 342 892